Patient satisfaction after first-line treatment for localized prostate cancer (in Germany)

A new article in the journal Anticancer Research suggests that patients had greater satisfaction after modern forms of external beam radiation therapy (EBRT) than after some other standard forms of first-line treatment. Of course the absolute truth of this conclusion may be affected by the details of the study.

The new NCCN patient guidelines — a great improvement over last time

We have now had the chance to look carefully through the new, patient-specific guidelines on prostate cancer issued by the National Comprehensive Cancer Network (NCCN) just before the Holidays. They are not perfect, but they are certainly a vast improvement over the NCCN’s first attempt.

NCCN issues completely revised edition of prostate cancer patient guidelines

The “New” Prostate Cancer InfoLink is pleased to see that — here in the USA — the National Comprehensive Cancer Network (NCCN) has just issued a fully revised, new edition of the NCCN Guidelines for Patients™ for Prostate Cancer (Version 1.2011).

The patients’ expectations and the doctors’ dilemmas

The following article was just published by Ranjana Srivastava, MD, in The New England Journal of Medicine under the title “Dealing with uncertainty in a time of plenty.”

Beyond the Abstract — Treatment options for localized prostate cancer

The following article, by Ravinder Mohan, MD, PhD, is reproduced from the UroToday web site with kind permission of Dr. Mohan and the publishers of UroToday. We had previously commented on the original article, published last month in American Family Physician.

Variation in the informational needs of men with localized prostate cancer

In a newly published paper based on work by a Swiss research team, the authors come to the  conclusion that there is vast variation in the informational needs of men diagnosed with relatively early stage prostate cancer. This will come as no great surprise to most prostate cancer support group leaders and other prostate cancer [...]

PCPs’ opinions about PSA testing and “shared decision-making”

A report in Family Medicine gives us some insight into the views of primary care physicians (PCPs) with respect to PSA testing for prostate cancer risk and the appropriate roles of the patient and the physician in the decision to have or not have PSA tests.

Five questions one newly diagnosed patient wanted answers to

Jeffrey Foster was diagnosed with early stage, low-risk prostate cancer in 2009. Like a lot of smart men, he realized quickly that he needed answers to a whole bunch of questions. Apparently he is still waiting for some of those answers, because

NCCN issues patient guidelines on prostate cancer diagnosis and management

At some point in the past 3 weeks or so, the National Comprehensive Cancer Network (NCCN) Foundation has quietly issued its new NCCN Guidelines for Patients™ on prostate cancer diagnosis and management.

Why men choose specific first-line types of management for localized prostate cancer

The need for patients diagnosed with early stage prostate cancer to be highly involved in the decision as to which form of management they wish to be given is well understood. However, there has been a relative dearth of data on why patients actually make their individual decisions.

A patient-centric approach to the discussion about testing for prostate cancer risk

There is no consensus about the appropriateness of widespread testing for risk of prostate cancer. While many guidelines recommend that primary care physicians have a structured conversation with their male patients about the appropriateness of such testing, we had not (before today) come across any sound guidance for the primary care community about how to have that discussion.

Informed choice and the right to appropriate PSA testing

Following the recent decision in the UK not to implement a broad, national, PSA-based, prostate cancer screening initiative (on which we have previously commented), many readers will be interested in the reactions and thoughts of John Neate, the executive director of the UK’s Prostate Cancer Charity, which appear in today’s issue of The Guardian newspaper.

“What prostate cancer patients want” — or is it?

According to preliminary data from a survey of prostate cancer patients in France and the UK, the key finding was that 72 percent of the participants “did not want the treatment for their condition to impact their lives.”

What newly diagnosed patients expect from prostate cancer treatment

A newly published study appearing in the Journal of the American Board of Family Medicine appears to demonstrate that patients newly diagnosed with localized prostate cancer grossly underestimate their life expectancy without treatment and grossly overestimate the survival benefit of treatment.

The Tuesday news update: March 10, 2009

Today’s news reports include items on: Risk for prostate cancer Patient decisions about sexual functionality and prostate cancer treatment Whole gland and focal cryotherapy Testosterone replacement after prostate cancer therapy and other items.

Follow

Get every new post delivered to your Inbox.

Join 269 other followers